Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 265238, 13 pages
http://dx.doi.org/10.1155/2015/265238
Research Article

Herb-Partitioned Moxibustion and the miRNAs Related to Crohn’s Disease: A Study Based on Rat Models

1Department of Integrated Traditional Chinese and Western Medicine, Huashan Hospital, Fudan University, Shanghai 200030, China
2Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
3Shanghai Research Institute of Acupuncture-Moxibustion and Meridians, Shanghai 200030, China

Received 2 December 2014; Accepted 5 February 2015

Academic Editor: Ilaria Lampronti

Copyright © 2015 Kai Wei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Wu, S. Zhang, T. Dassopoulos et al., “Identification of microRNAs associated with ileal and colonic Crohn's disease,” Inflammatory Bowel Diseases, vol. 16, no. 10, pp. 1729–1738, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. K. Podolsky, “Inflammatory bowel disease,” The New England Journal of Medicine, vol. 347, no. 6, pp. 417–429, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. J. X. Zhang, J. H. He, J. Wang, J. Song, H.-B. Lei, and W.-G. Dong, “Associations between PTPN2 polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysis,” Inflammation Research, vol. 63, no. 1, pp. 71–79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Kugathasan and D. Amre, “Inflammatory bowel disease–environmental modification and genetic determinants,” Pediatric Clinics of North America, vol. 53, no. 4, pp. 727–749, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. W. Carthew, “Gene regulation by microRNAs,” Current Opinion in Genetics and Development, vol. 16, no. 2, pp. 203–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. H. Chua, A. Armugam, and K. Jeyaseelan, “MicroRNAs: biogenesis, function and applications,” Current Opinion in Molecular Therapeutics, vol. 11, no. 2, pp. 189–199, 2009. View at Google Scholar · View at Scopus
  7. L. Wu, J. Fan, and J. G. Belasco, “MicroRNAs direct rapid deadenylation of mRNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 11, pp. 4034–4039, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Filipowicz, S. N. Bhattacharyya, and N. Sonenberg, “Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?” Nature Reviews Genetics, vol. 9, no. 2, pp. 102–114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Griffiths-Jones, H. K. Saini, S. van Dongen, and A. J. Enright, “miRBase: tools for microRNA genomics,” Nucleic Acids Research, vol. 36, no. 1, pp. D154–D158, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. B. P. Lewis, C. B. Burge, and D. P. Bartel, “Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets,” Cell, vol. 120, no. 1, pp. 15–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Ambros, “The functions of animal microRNAs,” Nature, vol. 431, no. 7006, pp. 350–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. E. A. Miska, “How microRNAs control cell division, differentiation and death,” Current Opinion in Genetics & Development, vol. 15, no. 5, pp. 563–568, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. G. A. Calin and C. M. Croce, “MicroRNA signatures in human cancers,” Nature Reviews Cancer, vol. 6, no. 11, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. K. M. Pauley, S. Cha, and E. K. L. Chan, “MicroRNA in autoimmunity and autoimmune diseases,” Journal of Autoimmunity, vol. 32, no. 3-4, pp. 189–194, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Lin, Q. Cao, J. Zhang et al., “MicroRNA expression patterns in indeterminate inflammatory bowel disease,” Modern Pathology, vol. 26, no. 1, pp. 148–154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Fasseu, X. Tréton, C. Guichard et al., “Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease,” PLoS ONE, vol. 5, no. 10, Article ID e13160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Joos, B. Brinkhaus, C. Maluche et al., “Acupuncture and moxibustion in the treatment of active Crohn's disease: a randomized controlled study,” Digestion, vol. 69, no. 3, pp. 131–139, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. C. H. Bao, J. M. Zhao, H. R. Liu et al., “Randomized controlled trial: moxibustion and acupuncture for the treatment of Crohn's disease,” World Journal of Gastroenterology, vol. 20, no. 31, pp. 11000–11011, 2014. View at Publisher · View at Google Scholar
  19. W. Kai, D. Zhang, D. Chuanzi et al., “Study on the regulating effect of moxibustion on NF-κB p65, TNF-α, and IL-1β in colons of CD rats,” World Chinese Medicine, vol. 8, no. 8, pp. 862–870, 2013 (Chinese). View at Google Scholar
  20. J. Hong, C.-H. Zhang, and X.-P. Ma, “Pathogenesis of inflammatory bowel disease and the action mechanism of moxibustion,” Journal of Acupuncture and Tuina Science, vol. 10, no. 3, pp. 174–180, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Wang, Y. Lu, L. Wu et al., “Moxibustion inhibits the ERK signaling pathway and intestinal fibrosis in rats with Crohn's disease,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 198282, 12 pages, 2013. View at Publisher · View at Google Scholar
  22. G. P. Morris, P. L. Beck, M. S. Herridge, W. T. Depew, M. R. Szewczuk, and J. L. Wallace, “Hapten-induced model of chronic inflammation and ulceration in the rat colon,” Gastroenterology, vol. 96, no. 3, pp. 795–803, 1989. View at Google Scholar · View at Scopus
  23. J. D. Butzner, R. Parmar, C. J. Bell, and V. Dalal, “Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat,” Gut, vol. 38, no. 4, pp. 568–573, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Vilaseca, A. Salas, F. Guarner, R. Rodriguez, M. Martinez, and J.-R. Malagelada, “Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis,” Gut, vol. 31, no. 5, pp. 539–544, 1990. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Edgar, M. Domrachev, and A. E. Lash, “Gene Expression Omnibus: NCBI gene expression and hybridization array data repository,” Nucleic Acids Research, vol. 30, no. 1, pp. 207–210, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. V. C. Hilliard, M. R. Frey, P. J. Dempsey, R. M. Peek Jr., and D. B. Polk, “TNF-α converting enzyme-mediated ErbB4 transactivation by TNF promotes colonic epithelial cell survival,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 301, no. 2, pp. G338–G346, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. R. Frey, K. L. Edelblum, M. T. Mullane, D. Liang, and D. B. Polk, “The ErbB4 growth factor receptor is required for colon epithelial cell survival in the presence of TNF,” Gastroenterology, vol. 136, no. 1, pp. 217–226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Schapansky, J. D. Nardozzi, F. Felizia, and M. J. LaVoie, “Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy,” Human Molecular Genetics, vol. 23, no. 16, pp. 4201–4214, 2014. View at Publisher · View at Google Scholar
  29. N. Dzamko, F. Inesta-Vaquera, J. Zhang et al., “The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor signaling,” PLoS ONE, vol. 7, no. 6, Article ID e39132, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. T. S. Stappenbeck, J. D. Rioux, A. Mizoguchi et al., “Crohn disease: a current perspective on genetics, autophagy and immunity,” Autophagy, vol. 7, no. 4, pp. 355–374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Liu, J. Lee, S. Krummey, W. Lu, H. Cai, and M. J. Lenardo, “The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease,” Nature Immunology, vol. 12, no. 11, pp. 1063–1070, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Kim, M.-S. Yang, D. Choi et al., “Impaired inflammatory responses in murine lrrk2-knockdown brain microglia,” PLoS ONE, vol. 7, no. 4, Article ID e34693, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. M. S. Moehle, P. J. Webber, T. Tse et al., “LRRK2 inhibition attenuates microglial inflammatory responses,” The Journal of Neuroscience, vol. 32, no. 5, pp. 1602–1611, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. E. A. Udofa, B. W. Stringer, P. Gade et al., “The transcription factor C/EBP-β mediates constitutive and LPS-inducible transcription of murine SerpinB2,” PLoS ONE, vol. 8, no. 3, Article ID e57855, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. X. M. Meng, X. R. Huang, J. Xiao et al., “Disruption of Smad4 impairs TGF-Β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro,” Kidney International, vol. 81, no. 3, pp. 266–279, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Pan, E. Ding, M. Hu, A. S. Lagoo, M. B. Datto, and S. A. Lagoo-Deenadayalan, “SMAD4 is required for development of maximal endotoxin tolerance,” Journal of Immunology, vol. 184, no. 10, pp. 5502–5509, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Zurhove, C. Nakajima, J. Herz, H. H. Bock, and P. May, “γ-secretase limits the inflammatory response through the processing of LRP1,” Science Signaling, vol. 1, no. 47, p. ra15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Prakash and A. Kumar, “Role of nuclear receptor on regulation of BDNF and neuroinflammation in hippocampus of β-amyloid animal model of Alzheimer's disease,” Neurotoxicity Research, vol. 25, no. 4, pp. 335–347, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. R. N. Saha, X. Liu, and K. Pahan, “Up-regulation of BDNF in astrocytes by TNF-alpha: a case for the neuroprotective role of cytokine,” Journal of Neuroimmune Pharmacology, vol. 1, no. 3, pp. 212–222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. Z. Cai, X. Zhang, G. Wang et al., “BDNF attenuates IL-1β-induced F-actin remodeling by inhibiting NF-κB signaling in hippocampal neurons,” Neuroendocrinology Letters, vol. 35, no. 1, pp. 13–19, 2014. View at Google Scholar · View at Scopus
  41. Q. Liu, J. Zheng, D.-D. Yin et al., “Monocyte to macrophage differentiation-associated (MMD) positively regulates ERK and Akt activation and TNF-α and NO production in macrophages,” Molecular Biology Reports, vol. 39, no. 5, pp. 5643–5650, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. K. O. Yaykasli, T. Oohashi, S. Hirohata et al., “ADAMTS9 activation by interleukin 1β via NFATc1 in OUMS-27 chondrosarcoma cells and in human chondrocytes,” Molecular and Cellular Biochemistry, vol. 323, no. 1-2, pp. 69–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Brest, P. Lapaquette, B. Mograbi, A. Darfeuille-Michaud, and P. Hofman, “Risk predisposition for Crohn disease: a ‘ménage à trois’ combining IRGM allele, miRNA and xenophagy,” Autophagy, vol. 7, no. 7, pp. 786–787, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. A. M. Zahm, M. Thayu, N. J. Hand, A. Horner, M. B. Leonard, and J. R. Friedman, “Circulating microRNA is a biomarker of pediatric Crohn disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 53, no. 1, pp. 26–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. Huang, T. Shi, Q. Zhou et al., “miR-141 regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn’s disease,” Gut, vol. 63, no. 8, pp. 1247–1257, 2014. View at Publisher · View at Google Scholar
  46. A. Paraskevi, G. Theodoropoulos, I. Papaconstantinou, G. Mantzaris, N. Nikiteas, and M. Gazouli, “Circulating MicroRNA in inflammatory bowel disease,” Journal of Crohn's and Colitis, vol. 6, no. 9, pp. 900–904, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Liu, A. Friggeri, Y. Yang, Y.-J. Park, Y. Tsuruta, and E. Abraham, “miR-147, a microRNA that is induced upon toll-like receptor stimulation, regulates murine macrophage inflammatory responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 37, pp. 15819–15824, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Tolfvenstam, A. Lindblom, M. J. Schreiber et al., “Characterization of early host responses in adults with dengue disease,” BMC Infectious Diseases, vol. 11, article 209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. C. G. Lee, S. McCarthy, M. Gruidl, C. Timme, and T. J. Yeatman, “MicroRNA-147 induces a mesenchymal-to-epithelial transition (MET) and reverses EGFR inhibitor resistance,” PLoS ONE, vol. 9, no. 1, Article ID e84597, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Uhlmann, H. Mannsperger, J. D. Zhang et al., “Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer,” Molecular Systems Biology, vol. 8, article 570, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. Z. Wang, H. Liao, Z. Deng et al., “MiRNA-205 affects infiltration and metastasis of breast cancer,” Biochemical and Biophysical Research Communications, vol. 441, no. 1, pp. 139–143, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Pennati, A. Lopergolo, V. Profumo et al., “MiR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells,” Biochemical Pharmacology, vol. 87, no. 4, pp. 579–597, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. P. A. Gregory, A. G. Bert, E. L. Paterson et al., “The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1,” Nature Cell Biology, vol. 10, no. 5, pp. 593–601, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Okamoto, K. Miyoshi, and Y. Murawaki, “miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells,” PLoS ONE, vol. 8, no. 10, Article ID e77623, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Karaayvaz, C. Zhang, S. Liang, K. R. Shroyer, and J. Ju, “Prognostic significance of miR-205 in endometrial cancer,” PLoS ONE, vol. 7, no. 4, Article ID e35158, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Lei, Y. Huang, and W. Gong, “MiR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN,” Oncology Reports, vol. 30, no. 6, pp. 2897–2902, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. I. N. Dahmke, C. Backes, J. Rudzitis-Auth et al., “Curcumin intake affects miRNA signature in murine melanoma with mmu-miR-205-5p most significantly altered,” PLoS ONE, vol. 8, no. 12, Article ID e81122, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Hemminki, X. Li, J. Sundquist, and K. Sundquist, “Cancer risks in Crohn disease patients,” Annals of Oncology, vol. 20, no. 3, pp. 574–580, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Min, L. Peng, Y. Yang, M. Guo, W. Wang, and G. Sun, “Microrna-155 is involved in the pathogenesis of ulcerative colitis by targeting FOXO3a,” Inflammatory Bowel Diseases, vol. 20, no. 4, pp. 652–659, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. X. Feng, H. Wang, S. Ye et al., “Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB Inhibitor IκBα,” PLoS ONE, vol. 7, no. 12, Article ID e52782, 2012. View at Publisher · View at Google Scholar · View at Scopus